Inventor
LANDOLFI NICHOLAS F
US19 patents
⚠️ This page may combine multiple inventors who share the name “LANDOLFI NICHOLAS F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WILLIAMS MARNA
6 patentsUS8461306B2Jun 11, 2013
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA10 citations92
US8445646B2May 21, 2013
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA8 citations83
US8444980B2May 21, 2013
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA8 citations83
US8436146B2May 7, 2013
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA7 citations83
US8133981B2Mar 13, 2012
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA6 citations83
US8088898B2Jan 3, 2012
Therapeutic use of anti-CS1 antibodies
WILLIAMS MARNA7 citations83
PROTEIN DESIGN LABS INC
4 patentsUS6329511B1Dec 11, 2001
Humanized antibodies to γ-interferon
PROTEIN DESIGN LABS INC308 citations99
US5349053ASep 20, 1994
Chimeric ligand/immunoglobulin molecules and their uses
PROTEIN DESIGN LABS INC590 citations99
US5693762ADec 2, 1997
Humanized immunoglobulins
PROTEIN DESIGN LABS INC5,271 citations98
US5882644AMar 16, 1999
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
PROTEIN DESIGN LABS INC121 citations97
ABBOTT BIOTHERAPEUTICS CORP
3 patentsUS8008450B2Aug 30, 2011
Therapeutic use of anti-CS1 antibodies
ABBOTT BIOTHERAPEUTICS CORP64 citations97
US8349330B2Jan 8, 2013
Therapeutic use of anti-CS1 antibodies
ABBOTT BIOTHERAPEUTICS CORP8 citations83
US7935793B2May 3, 2011
Treatment of inflammatory bowel diseases with anti-IP-10 antibodies
ABBOTT BIOTHERAPEUTICS CORP17 citations79